[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-18190":3,"doc-seo-18190":27},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":19,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"table_of_contents":24,"faqs":24,"seo_title":13,"seo_description":14,"update_tm":25,"read_time":26},18190,7971461741311,"Ophelia","https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826",8,"Research & Report","Hydrophilic Coating Modified Nano-Liposome Drug Carrier for Osteoarthritis Treatment","Local inter-articular injection for osteoarthritis requires prolonged retention in the synovial joint, restoration of degraded-cartilage lubrication, and reduction of synovial inflammation. A hydrophilic coating modified nano-liposome drug carrier (PMPC-Lipo) based on poly(MPC) was developed to restore hydration lubrication and evade macrophage recognition, prolonging joint retention. Encapsulated gallic acid (GA) scavenges reactive oxygen species and helps rebalance inflammatory chondrocyte matrix secretion.","cbCaic0qqqhwbl5b","https://ap.wps.com/l/cbCaic0qqqhwbl5b","pdf",10443341,15,1,13,"English","en","",1776585084,33,{"code":4,"msg":28,"data":29},"ok",{"site_id":30,"language":23,"slug":31,"title":13,"keywords":24,"description":14,"schema_data":32,"social_meta":67,"head_meta":70,"extra_data":72,"updated_unix":25},105,"hydrophilic-coating-modified-nano-liposome-drug-carrier-for-osteoarthritis-treatment",{"@graph":33,"@context":66},[34,51],{"@type":35,"itemListElement":36},"BreadcrumbList",[37,41,45,48],{"item":38,"name":39,"@type":40,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":42,"name":43,"@type":40,"position":44},"https://docshare.wps.com/document/","Document",2,{"item":46,"name":12,"@type":40,"position":47},"https://docshare.wps.com/document/research-report/",3,{"item":49,"name":13,"@type":40,"position":50},"https://docshare.wps.com/document/hydrophilic-coating-modified-nano-liposome-drug-carrier-for-osteoarthritis-treatment/18190/",4,{"url":49,"name":13,"@type":52,"author":53,"headline":13,"publisher":55,"fileFormat":58,"description":14,"dateModified":59,"datePublished":60,"encodingFormat":58,"isAccessibleForFree":61,"interactionStatistic":62},"DigitalDocument",{"name":9,"@type":54},"Person",{"url":38,"name":56,"@type":57},"DocShare","Organization","application/pdf","2026-06-04","2026-04-19",true,{"@type":63,"interactionType":64,"userInteractionCount":19},"InteractionCounter",{"@type":65},"ViewAction","https://schema.org",{"og:url":68,"og:type":69,"og:title":13,"og:site_name":56,"og:description":14},"https://docshare.wps.com/document/hydrophilic-coating-modified-nano-liposome-drug-carrier-for-osteoarthritis-treatment/18190","article",{"robots":71,"canonical":68},"index,follow",{"doc_id":7,"site_id":30}]